TRANSCODE THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TRANSCODE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $8.85M, a 45.47% increase year-over-year.
- TRANSCODE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $2.45M, a 66.27% decline year-over-year.
- TRANSCODE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $785.20K, a 87.91% decline year-over-year.
- TRANSCODE THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $6.09M, a 415.56% increase year-over-year.
- TRANSCODE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $10.09M, a 11.48% decline from fiscal 2024.
- TRANSCODE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $11.40M, a 28.37% decline from fiscal 2023.
- TRANSCODE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $15.91M.
- TRANSCODE THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2021 was $25.40M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $10.09M 10-K · filed 2026-04-15 | |
| 2025-03-31 | $8.85M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $11.40M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $2.45M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $785.20K 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $6.09M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $15.91M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $7.26M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $6.50M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $1.18M 10-Q · filed 2024-11-14 | |
| 2021-12-31 | $25.40M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $25.40M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |